Hamza, Suzan A., Namir I. A. Haddad, and Gheyath AL Gawwam. 2026. “The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study”. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES, February, 335-45. https://doi.org/10.29284/x4mwhb26.